View this email in your browser ([link removed])
[link removed] January 15, 2025
** Community-Led Monitoring, PrEP Advances, and What’s Next for Global Health
------------------------------------------------------------
Dear Advocate,
Welcome to January 2025! This update shares new resources to keep you informed and inspired in the fight for choice, science, equity and sustainability in the HIV response in 2025 and beyond.
New Podcast Episode Alert!
[link removed]
Tune in to our latest Advocacy Chronicles ([link removed]) podcast as we spotlight the transformative power of Community-Led Monitoring ([link removed]) (CLM) in Malawi’s HIV response. David Kamkwamba is leading journalist and advocate, former chair of the Civil Society Advocacy Forum on HIV and related diseases ([link removed]) and a COMPASS ([link removed]) partner. In this podcast, he shares how CLM is improving HIV services, forging collaboration between communities and government, and strengthening the health system.
Listen Now ([link removed])
Revisit Our Episode on HIV Prevention and the US Administration
Podcast
[link removed]
As the US prepares this week for its presidential inauguration and confirmation hearings for Cabinet nominees, it’s a great time to listen to KFF’s Jen Kates ([link removed]) and AVAC’s Suraj Madoori ([link removed]) lay out the challenges and the priorities in 2025 and beyond. In the days, months and years ahead, advocacy for choice, freedom, science, and rights will require intentional strategies to protect hard fought gains in HIV treatment and prevention and in global health generally. It’s imperative to understand the implications for the global AIDS response, and to safeguard policies and programs that advance it.
Listen Now ([link removed])
Save the Date, March 5
Webinar
March 5, 2025 I 12:00 - 1:30pm EST
[link removed]
** Advancing Clinician Support in the United States Through a Unique Distance-Based Model
------------------------------------------------------------
Join the TCA and the National Clinician Consultation Center (NCCC) for a webinar featuring NCCC’s innovative, cost-free teleconsultation program, which provide a free, real-time, expert guidance on HIV, viral hepatitis, and substance use to clinicians across the US, regardless of location or clinical setting. Participants will discuss this model and strategies to adapt it for global healthcare challenges.
Register Now ([link removed])
Navigating the PrEP Landscape
With a growing number of PrEP options in, or soon in the market, and others in advanced development, and an increase in PrEP initiations worldwide, the future of PrEP has never been more exciting – and challenging.
[link removed]
** Global PrEP Tracker
------------------------------------------------------------
AVAC’s interactive Global PrEP Tracker provides up-to-date information on PrEP initiations by country and delivery model, offering insights into the progress and impact of PrEP programs around the world.
explore the PrEP tracker ([link removed])
[link removed]
** Opinion: The world has a new HIV prevention drug. Let’s use it
------------------------------------------------------------
A new op-ed ([link removed]) by Jirair Ratevosian ([link removed]) and Mitchell Warren ([link removed]) in Devex discusses the potential of lenacapavir, an every six-month injectable pre-exposure prophylaxis (PrEP) medication, to transform the HIV response, but only if it is rolled out with speed, scale and equity.
read the piece ([link removed])
As we navigate an uncertain political landscape and embrace the promise of innovative PrEP products, advocacy will remain our most powerful tool.
Best,
AVAC
Follow us @hivpxresearch ([link removed])
[link removed] [link removed] [link removed]
Share this issue ([link removed])
AVAC Global Advocacy for HIV Prevention
+1 212 796 6423
[email protected] (mailto:
[email protected]) www.avac.org ([link removed])
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences ([link removed]) | Unsubscribe ([link removed])
